Use of multiple sclerosis medicine Lemtrada restricted while EMA review is ongoing

12 April 2019 - EMA has started a review of the multiple sclerosis medicine Lemtrada (alemtuzumab) following new reports of ...

Read more →

Missing from the PBM hearings: value based drug reimbursement

11 April 2019 - This week, committees in both the Senate and House of Representatives used their power to shine ...

Read more →

Select committee inquiry into PHARMAC would be too slow - Labour

12 April 2019 - The Government says a select committee inquiry into PHARMAC's drug-buying processes would take longer than current ...

Read more →

Peters accuses Bennett of using people's illnesses to gain 'political points' in exchange about PHARMAC funding

11 April 2019 - Winston Peters accused Paula Bennett of using people's illnesses to gain "political points" during an exchange ...

Read more →

Labour MP rejects claims she said Health Minister nixed PHARMAC inquiry

11 April 2019 - Labour MP health select committee chair Louisa Wall is rejecting claims she told the husband of a ...

Read more →

Official inquiry into PHARMAC necessary

10 April 2019 - Today National MP Michael Woodhouse is set to table a motion calling on the Health Select ...

Read more →

Health insurers welcome Coalition review on natural therapies

8 April 2019 - Health insurers have welcomed a Coalition pledge to reconsider a ban on cover for natural therapies ...

Read more →

FDA reform: it’s time to act, but not as an independent agency

19 March 2019 - In a rare exercise in bipartisan leadership, former FDA commissioners of both political parties called, in ...

Read more →

Women with advanced breast cancer ask health select committee for PHARMAC review

13 March 2019 - Ten women today spoke one after the other, telling a committee of MPs how desperately they ...

Read more →

Outcomes and impacts of 10 year HTA implementation in Taiwan

28 February 2019 - In 2007, Taiwan began conducting health technology assessments to support the National Health Insurance Administration in ...

Read more →

After 16 reviews we know how to fix health care, experts say

28 February 2019 - After 16 national reviews in 35 years, the road map for improving the health care system ...

Read more →

Details of Doug Ford government’s health care overhaul, including new super agency, coming Tuesday

26 February 2019 - The Ontario government will announce its long-rumoured overhaul of the province’s health care system on Tuesday, ...

Read more →

Procedural update on submission of Type I variations to EMA in March, April and May 2019

26 February 2019 - EMA is encouraging marketing authorisation holders intending to submit Brexit-related Type IA and Type IB variations ...

Read more →

PHARMAC to review its practices following criticism of breast cancer drug funding

13 February 2019 - The government's drug-buying agency has announced it has begun an internal review following a petition and ...

Read more →

How procurement judges the value of medical technologies: a review of health care tenders

8 February 2019 - Procurement's important role in healthcare decision making has encouraged criticism and calls for greater collaboration with health ...

Read more →